BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1899298)

  • 1. Immunogenicity of class I+, class II- hepatocytes.
    Almond PS; Bumgardner GL; Chen S; Platt J; Payne WD; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):108-9. PubMed ID: 1899298
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of class II antigen expression on hepatocytes profoundly affects CTL development in vitro and in vivo.
    Clemmings SM; Alan TJ; Bumgardner GL; Ascher NL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):817-8. PubMed ID: 1990700
    [No Abstract]   [Full Text] [Related]  

  • 3. Memory T cells generated in vitro to class I+, II- hepatocytes.
    Bumgardner GL; Almond PS; Chen S; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):104-5. PubMed ID: 1990489
    [No Abstract]   [Full Text] [Related]  

  • 4. Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture.
    So SK; Wilkes LM; Platt JL; Ascher NL; Simmons RL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):251-2. PubMed ID: 3274778
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 6. L3T4+,LyT2- and LyT2+,L3T4- T cells participate in the generation of allospecific cytotoxicity in response to MHC class I+ hepatocytes.
    Bumgardner GL; Cahill DR; Chen S; Bach FH; Ascher NL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):421-2. PubMed ID: 2523139
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of a role for TNF-alpha in cytolysis by CD4+, class II MHC-restricted cytotoxic T cells.
    Tite JP
    Immunology; 1990 Oct; 71(2):208-12. PubMed ID: 2228021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL.
    McCarthy SA; Singer A
    J Immunol; 1986 Nov; 137(10):3087-92. PubMed ID: 3095422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of class I antigen expression with immunogenicity.
    Almond PS; Baumgardner GL; Chen S; Cunningham TR; Payne WD; Matas AJ
    Curr Surg; 1990; 47(4):262-4. PubMed ID: 2397644
    [No Abstract]   [Full Text] [Related]  

  • 11. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo.
    McKinney EC; Streilein JW
    J Immunol; 1989 Sep; 143(5):1560-4. PubMed ID: 2788187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that a "four-cell cluster" may prime cytotoxic T-cells during graft rejection.
    Lee R; Glimcher LH; Auchincloss H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):847-9. PubMed ID: 8442245
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative in vitro immunogenicity of cultured murine islets and hepatocytes.
    Meloche M; Bumgardner G; Stock P; Chen S; Ascher NL; Sutherland DE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2682-4. PubMed ID: 2523160
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection.
    Ladel CH; Flesch IE; Arnoldi J; Kaufmann SH
    J Immunol; 1994 Oct; 153(7):3116-22. PubMed ID: 7726898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
    Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.